Irinotecan (CPT-11) induced colitis: report of a case and review of Food and Drug Administration MEDWATCH reporting

Saved in:

Bibliographic Details
Published in:	Gastrointestinal endoscopy Vol. 50; no. 6; pp. 841 - 844
Main Authors:	Sears, Stephen, McNally, Peter, Bachinski, Matthew S.Z., Avery, Robert
Format:	Journal Article
Language:	English
Published:	New York, NY Mosby, Inc 01-12-1999 Elsevier
Subjects:	Adenocarcinoma - drug therapy Adenocarcinoma - pathology Adenocarcinoma - secondary Adverse Drug Reaction Reporting Systems Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Agents, Phytogenic - adverse effects Biological and medical sciences Camptothecin - administration & dosage Camptothecin - adverse effects Camptothecin - analogs & derivatives Chemotherapy, Adjuvant Colitis - chemically induced Colitis - pathology Colonoscopy Drug toxicity and drugs side effects treatment Female Gastrointestinal Hemorrhage - chemically induced Gastrointestinal Hemorrhage - pathology Humans Intestinal Mucosa - drug effects Intestinal Mucosa - pathology Irinotecan Liver Neoplasms - drug therapy Liver Neoplasms - pathology Liver Neoplasms - secondary Medical sciences Middle Aged Neoplasm Staging Pharmacology. Drug treatments Sigmoid Neoplasms - drug therapy Sigmoid Neoplasms - pathology Toxicity: digestive system United States United States Food and Drug Administration Antineoplastic agent Human Hemorrhage Case study Irinotecan Histopathology Colonoscopy Secondary effect Digestive diseases Intestinal disease Female Endoscopy Colitis Pharmacokinetics Elderly Bibliographic review
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0016-5107 1097-6779
DOI:	10.1016/S0016-5107(99)70171-9